CD4 and COVID-19: Unlike healthy controls, who usually possess the majority of circulating PBMCs, participants with COVID-19 and influenza exhibited distinct inflammatory profiles characterized by declining B-cell counts and substantial decreases in CD4 and CD8 T cells [50].